Exploring the Risk Factors and Possible Role of Calcium in Infective Endocarditis
Abstract
:1. Introduction
2. Pathophysiology of IE
3. Risk Factors for IE
4. Diagnosis of IE
5. Treatment of IE
6. Biomarkers for the Diagnosis of IE
7. Clinical Values of Serum Calcium as a Biomarker for Infectious Disease
7.1. Role of Calcium in the Pathogenesis of Infectious Endocarditis
7.2. Hypercalcemia and Infectious Endocarditis
7.3. Hypocalcemia and Infectious Endocarditis
8. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bin Abdulhak, A.A.; Baddour, L.M.; Erwin, P.J.; Hoen, B.; Chu, V.H.; Mensah, G.A.; Tleyjeh, I.M. Global and regional burden of infective endocarditis, 1990–2010: A systematic review of the literature. Glob. Heart 2014, 9, 131–143. [Google Scholar] [CrossRef] [PubMed]
- Murdoch, D.R.; Corey, G.R.; Hoen, B.; Miro, J.M.; Fowler, V.G., Jr.; Bayer, A.S.; Karchmer, A.W.; Olaison, L.; Pappas, P.A.; Moreillon, P.; et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study. Arch. Intern. Med. 2009, 169, 463–473. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ambrosioni, J.; Hernandez-Meneses, M.; Tellez, A.; Pericas, J.; Falces, C.; Tolosana, J.M.; Vidal, B.; Almela, M.; Quintana, E.; Llopis, J.; et al. The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century. Curr. Infect. Dis. Rep. 2017, 19, 21. [Google Scholar] [CrossRef]
- Cahill, T.J.; Baddour, L.M.; Habib, G.; Hoen, B.; Salaun, E.; Pettersson, G.B.; Schafers, H.J.; Prendergast, B.D. Challenges in Infective Endocarditis. J. Am. Coll. Cardiol. 2017, 69, 325–344. [Google Scholar] [CrossRef] [PubMed]
- Duszyk, A.; Bierzynska, M.; Radzikowska, Z.; Milanowski, P.; Kus, R.; Suffczynski, P.; Michalska, M.; Labecki, M.; Zwolinski, P.; Durka, P. Towards an optimization of stimulus parameters for brain-computer interfaces based on steady state visual evoked potentials. PLoS ONE 2014, 9, e112099. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cahill, T.J.; Prendergast, B.D. Infective endocarditis. Lancet 2016, 387, 882–893. [Google Scholar] [CrossRef] [Green Version]
- Toyoda, N.; Chikwe, J.; Itagaki, S.; Gelijns, A.C.; Adams, D.H.; Egorova, N.N. Trends in Infective Endocarditis in California and New York State, 1998–2013. JAMA 2017, 317, 1652–1660. [Google Scholar] [CrossRef]
- Keynan, Y.; Rubinstein, E. Pathophysiology of infective endocarditis. Curr. Infect. Dis. Rep. 2013, 15, 342–346. [Google Scholar] [CrossRef]
- Salvador, V.B.; Chapagain, B.; Joshi, A.; Brennessel, D.J. Clinical Risk Factors for Infective Endocarditis in Staphylococcus aureus Bacteremia. Tex. Heart Inst. J. 2017, 44, 10–15. [Google Scholar] [CrossRef] [Green Version]
- Fowler, V.G.; Durack, D.T.; Selton-Suty, C.; Athan, E.; Bayer, A.S.; Chamis, A.L.; Dahl, A.; DiBernardo, L.; Durante-Mangoni, E.; Duval, X.; et al. The 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin. Infect. Dis. 2023, ciad271. [Google Scholar] [CrossRef]
- Durack, D.T.; Lukes, A.S.; Bright, D.K. New criteria for diagnosis of infective endocarditis: Utilization of specific echocardiographic findings. Duke Endocarditis Service. Am. J. Med. 1994, 96, 200–209. [Google Scholar] [CrossRef]
- Habib, G.; Lancellotti, P.; Antunes, M.J.; Bongiorni, M.G.; Casalta, J.P.; Del Zotti, F.; Dulgheru, R.; El Khoury, G.; Erba, P.A.; Iung, B.; et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur. Heart J. 2015, 36, 3075–3128. [Google Scholar]
- Habib, G.; Derumeaux, G.; Avierinos, J.F.; Casalta, J.P.; Jamal, F.; Volot, F.; Garcia, M.; Lefevre, J.; Biou, F.; Maximovitch-Rodaminoff, A.; et al. Value and limitations of the Duke criteria for the diagnosis of infective endocarditis. J. Am. Coll. Cardiol. 1999, 33, 2023–2029. [Google Scholar] [CrossRef] [Green Version]
- San Roman, J.A.; Vilacosta, I.; Lopez, J.; Revilla, A.; Arnold, R.; Sevilla, T.; Rollan, M.J. Role of transthoracic and transesophageal echocardiography in right-sided endocarditis: One echocardiographic modality does not fit all. J. Am. Soc. Echocardiogr. 2012, 25, 807–814. [Google Scholar] [CrossRef]
- Selton-Suty, C.; Celard, M.; Le Moing, V.; Doco-Lecompte, T.; Chirouze, C.; Iung, B.; Strady, C.; Revest, M.; Vandenesch, F.; Bouvet, A.; et al. Preeminence of Staphylococcus aureus in infective endocarditis: A 1-year population-based survey. Clin. Infect. Dis. 2012, 54, 1230–1239. [Google Scholar] [CrossRef] [Green Version]
- Gould, F.K.; Denning, D.W.; Elliott, T.S.; Foweraker, J.; Perry, J.D.; Prendergast, B.D.; Sandoe, J.A.; Spry, M.J.; Watkin, R.W.; Working Party of the British Society for Antimicrobial Chemotherapy. Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: A report of the Working Party of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 2012, 67, 269–289. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Anantha Narayanan, M.; Mahfood Haddad, T.; Kalil, A.C.; Kanmanthareddy, A.; Suri, R.M.; Mansour, G.; Destache, C.J.; Baskaran, J.; Mooss, A.N.; Wichman, T.; et al. Early versus late surgical intervention or medical management for infective endocarditis: A systematic review and meta-analysis. Heart 2016, 102, 950–957. [Google Scholar] [CrossRef] [PubMed]
- Prendergast, B.D.; Tornos, P. Surgery for infective endocarditis: Who and when? Circulation 2010, 121, 1141–1152. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Knudsen, J.B.; Fuursted, K.; Petersen, E.; Wierup, P.; Molgaard, H.; Poulsen, S.H.; Egeblad, H. Infective endocarditis: A continuous challenge. The recent experience of a European tertiary center. J. Heart Valve Dis. 2009, 18, 386–394. [Google Scholar]
- Yang, A.; Tan, C.; Daneman, N.; Hansen, M.S.; Habib, G.; Salaun, E.; Lavoute, C.; Hubert, S.; Adhikari, N.K.J. Clinical and echocardiographic predictors of embolism in infective endocarditis: Systematic review and meta-analysis. Clin. Microbiol. Infect. 2019, 25, 178–187. [Google Scholar] [CrossRef]
- Salinas, G.A.; Bustamante, H.L.; Lanas, Z.F.; Soto, V.A.; Garcia, B.M.; Bartolotti, H.C. Non-bacterial thrombotic endocarditis. Report of one case. Rev. Med. Chil. 2017, 145, 1353–1358. [Google Scholar]
- Lee, A.; Mirrett, S.; Reller, L.B.; Weinstein, M.P. Detection of bloodstream infections in adults: How many blood cultures are needed? J. Clin. Microbiol. 2007, 45, 3546–3548. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hoen, B.; Alla, F.; Selton-Suty, C.; Beguinot, I.; Bouvet, A.; Briancon, S.; Casalta, J.P.; Danchin, N.; Delahaye, F.; Etienne, J.; et al. Changing profile of infective endocarditis: Results of a 1-year survey in France. JAMA 2002, 288, 75–81. [Google Scholar] [CrossRef]
- Zhang, S.; Zhang, X.; Yu, W.; Lin, Z.; Chen, D. Infection biomarkers in assisting the judgement of blood stream infection and patient prognosis: A retrospective study incorporating principal components analysis. Ann. Transl. Med. 2020, 8, 1581. [Google Scholar] [CrossRef] [PubMed]
- Berk, B.C.; Weintraub, W.S.; Alexander, R.W. Elevation of C-reactive protein in “active” coronary artery disease. Am. J. Cardiol. 1990, 65, 168–172. [Google Scholar] [CrossRef] [PubMed]
- Pietila, K.; Harmoinen, A.; Hermens, W.; Simoons, M.L.; Van de Werf, F.; Verstraete, M. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur. Heart J. 1993, 14, 915–919. [Google Scholar] [CrossRef] [PubMed]
- Zampino, R.; Iossa, D.; Ursi, M.P.; Bertolino, L.; Andini, R.; Molaro, R.; Fabrazzo, O.; Leonardi, S.; Atripaldi, L.; Durante-Mangoni, E. Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis. BMC Infect. Dis. 2021, 21, 23. [Google Scholar] [CrossRef]
- Hatipoglu, M.; Ulcay, A.; Karagoz, E.; Turhan, V. Role of procalcitonin in the diagnosis of infective endocarditis. Am. J. Emerg. Med. 2014, 32, 285. [Google Scholar] [CrossRef]
- Mueller, C.; Huber, P.; Laifer, G.; Mueller, B.; Perruchoud, A.P. Procalcitonin and the early diagnosis of infective endocarditis. Circulation 2004, 109, 1707–1710. [Google Scholar] [CrossRef] [Green Version]
- Cornelissen, C.G.; Frechen, D.A.; Schreiner, K.; Marx, N.; Kruger, S. Inflammatory parameters and prediction of prognosis in infective endocarditis. BMC Infect. Dis. 2013, 13, 272. [Google Scholar] [CrossRef] [Green Version]
- Cuculi, F.; Toggweiler, S.; Auer, M.; der Maur Ch, A.; Zuber, M.; Erne, P. Serum procalcitonin has the potential to identify Staphylococcus aureus endocarditis. Eur. J. Clin. Microbiol. Infect. Dis. 2008, 27, 1145–1149. [Google Scholar] [CrossRef] [PubMed]
- Knudsen, J.B.; Fuursted, K.; Petersen, E.; Wierup, P.; Molgaard, H.; Poulsen, S.H.; Egeblad, H. Procalcitonin in 759 patients clinically suspected of infective endocarditis. Am. J. Med. 2010, 123, 1121–1127. [Google Scholar] [CrossRef] [PubMed]
- Bray, C.; Bell, L.N.; Liang, H.; Haykal, R.; Kaiksow, F.; Mazza, J.J.; Yale, S.H. Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine. WMJ 2016, 115, 317–321. [Google Scholar]
- Lamas, C.C.; Eykyn, S.J. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: Analysis of 118 pathologically proven cases. Clin. Infect. Dis. 1997, 25, 713–719. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Olson, J.D. D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications. Adv. Clin. Chem. 2015, 69, 1–46. [Google Scholar] [PubMed]
- Wells, P.S.; Anderson, D.R.; Rodger, M.; Forgie, M.; Kearon, C.; Dreyer, J.; Kovacs, G.; Mitchell, M.; Lewandowski, B.; Kovacs, M.J. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N. Engl. J. Med. 2003, 349, 1227–1235. [Google Scholar] [CrossRef] [Green Version]
- Lin, Y.W.; Jiang, M.; Wei, X.B.; Huang, J.L.; Su, Z.; Wang, Y.; Chen, J.Y.; Yu, D.Q. Prognostic value of D-dimer for adverse outcomes in patients with infective endocarditis: An observational study. BMC Cardiovasc. Disord. 2021, 21, 279. [Google Scholar] [CrossRef]
- Kahveci, G.; Bayrak, F.; Mutlu, B.; Bitigen, A.; Karaahmet, T.; Sonmez, K.; Izgi, A.; Degertekin, M.; Basaran, Y. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis. Am. J. Cardiol. 2007, 99, 1429–1433. [Google Scholar] [CrossRef]
- Shiue, A.B.; Stancoven, A.B.; Purcell, J.B.; Pinkston, K.; Wang, A.; Khera, A.; de Lemos, J.A.; Peterson, G.E. Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis. Am. J. Cardiol. 2010, 106, 1011–1015. [Google Scholar] [CrossRef]
- Dzikowska-Diduch, O.; Kurnicka, K.; Lichodziejewska, B.; Dudzik-Niewiadomska, I.; Machowski, M.; Roik, M.; Wisniewska, M.; Siwiec, J.; Staniszewska, I.M.; Pruszczyk, P. Electrocardiogram, Echocardiogram and NT-proBNP in Screening for Thromboembolism Pulmonary Hypertension in Patients after Pulmonary Embolism. J. Clin. Med. 2022, 11, 7369. [Google Scholar] [CrossRef]
- Lai, C.C.; Sung, M.I.; Ho, C.H.; Liu, H.H.; Chen, C.M.; Chiang, S.R.; Chao, C.M.; Liu, W.L.; Hsing, S.C.; Cheng, K.C. The prognostic value of N-terminal proB-type natriuretic peptide in patients with acute respiratory distress syndrome. Sci. Rep. 2017, 7, 44784. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chew, J.S.; Saleem, M.; Florkowski, C.M.; George, P.M. Cystatin C—A paradigm of evidence based laboratory medicine. Clin. Biochem. Rev. 2008, 29, 47–62. [Google Scholar] [PubMed]
- Benoit, S.W.; Ciccia, E.A.; Devarajan, P. Cystatin C as a biomarker of chronic kidney disease: Latest developments. Expert Rev. Mol. Diagn. 2020, 20, 1019–1026. [Google Scholar] [CrossRef] [PubMed]
- Bjurman, C.; Snygg-Martin, U.; Olaison, L.; Fu, M.L.; Hammarsten, O. Cystatin C in a composite risk score for mortality in patients with infective endocarditis: A cohort study. BMJ Open 2012, 2, e000856. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Purcell, J.B.; Patel, M.; Khera, A.; de Lemos, J.A.; Forbess, L.W.; Baker, S.; Cabell, C.H.; Peterson, G.E. Relation of troponin elevation to outcome in patients with infective endocarditis. Am. J. Cardiol. 2008, 101, 1479–1481. [Google Scholar] [CrossRef]
- Gucuk Ipek, E.; Guray, Y.; Acar, B.; Kafes, H.; Dinc Asarcikli, L.; Cabuk, G.; Demirkan, B.; Kuyumcu, M.S.; Guray, U. The usefulness of serum troponin levels to predict 1-year survival rates in infective endocarditis. Int. J. Infect. Dis. 2015, 34, 71–75. [Google Scholar] [CrossRef] [Green Version]
- Tiwari, R.P.; Jain, A.; Khan, Z.; Kohli, V.; Bharmal, R.N.; Kartikeyan, S.; Bisen, P.S. Cardiac troponins I and T: Molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction. Mol. Diagn. Ther. 2012, 16, 371–381. [Google Scholar] [CrossRef]
- Zhang, L.; Zhu, T.; Miao, H.; Liang, B. The Calcium Binding Protein S100A11 and Its Roles in Diseases. Front. Cell Dev. Biol. 2021, 9, 693262. [Google Scholar] [CrossRef]
- Xia, C.; Braunstein, Z.; Toomey, A.C.; Zhong, J.; Rao, X. S100 Proteins as an Important Regulator of Macrophage Inflammation. Front. Immunol. 2017, 8, 1908. [Google Scholar] [CrossRef] [Green Version]
- Snipsoyr, M.G.; Ludvigsen, M.; Petersen, E.; Wiggers, H.; Honore, B. A systematic review of biomarkers in the diagnosis of infective endocarditis. Int. J. Cardiol. 2016, 202, 564–570. [Google Scholar] [CrossRef]
- Andres Cerezo, L.; Hulejova, H.; Sumova, B.; Kropackova, T.; Krystufkova, O.; Klein, M.; Mann, H.F.; Zamecnik, J.; Pecha, O.; Pavelka, K.; et al. Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis. Cytokine 2019, 116, 13–20. [Google Scholar] [CrossRef]
- Thuny, F.; Textoris, J.; Amara, A.B.; Filali, A.E.; Capo, C.; Habib, G.; Raoult, D.; Mege, J.L. The gene expression analysis of blood reveals S100A11 and AQP9 as potential biomarkers of infective endocarditis. PLoS ONE 2012, 7, e31490. [Google Scholar] [CrossRef] [Green Version]
- da Silva, I.V.; Garra, S.; Calamita, G.; Soveral, G. The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker. Biomolecules 2022, 12, 897. [Google Scholar] [CrossRef] [PubMed]
- Kerr, J.R. Cell adhesion molecules in the pathogenesis of and host defence against microbial infection. Mol. Pathol. 1999, 52, 220–230. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Golias, C.; Batistatou, A.; Bablekos, G.; Charalabopoulos, A.; Peschos, D.; Mitsopoulos, P.; Charalabopoulos, K. Physiology and pathophysiology of selectins, integrins, and IgSF cell adhesion molecules focusing on inflammation. A paradigm model on infectious endocarditis. Cell Commun. Adhes. 2011, 18, 19–32. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hwang, S.J.; Ballantyne, C.M.; Sharrett, A.R.; Smith, L.C.; Davis, C.E.; Gotto, A.M., Jr.; Boerwinkle, E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 1997, 96, 4219–4225. [Google Scholar] [CrossRef] [PubMed]
- Soderquist, B.; Sundqvist, K.G.; Vikerfors, T. Adhesion molecules (E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)) in sera from patients with Staphylococcus aureus bacteraemia with or without endocarditis. Clin. Exp. Immunol. 1999, 118, 408–411. [Google Scholar] [CrossRef]
- Araujo, I.R.; Ferrari, T.C.; Teixeira-Carvalho, A.; Campi-Azevedo, A.C.; Rodrigues, L.V.; Guimaraes Junior, M.H.; Barros, T.L.; Gelape, C.L.; Sousa, G.R.; Nunes, M.C. Cytokine Signature in Infective Endocarditis. PLoS ONE 2015, 10, e0133631. [Google Scholar] [CrossRef]
- Watkin, R.W.; Harper, L.V.; Vernallis, A.B.; Lang, S.; Lambert, P.A.; Ranasinghe, A.M.; Elliott, T.S. Pro-inflammatory cytokines IL6, TNF-alpha, IL1beta, procalcitonin, lipopolysaccharide binding protein and C-reactive protein in infective endocarditis. J. Infect. 2007, 55, 220–225. [Google Scholar] [CrossRef]
- Ridker, P.M.; Rifai, N.; Stampfer, M.J.; Hennekens, C.H. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101, 1767–1772. [Google Scholar] [CrossRef] [Green Version]
- Habib, G.; Badano, L.; Tribouilloy, C.; Vilacosta, I.; Zamorano, J.L.; Galderisi, M.; Voigt, J.U.; Sicari, R.; Cosyns, B.; Fox, K.; et al. Recommendations for the practice of echocardiography in infective endocarditis. Eur. J. Echocardiogr. 2010, 11, 202–219. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Saeedan, M.B.; Wang, T.K.M.; Cremer, P.; Wahadat, A.R.; Budde, R.P.J.; Unai, S.; Pettersson, G.B.; Bolen, M.A. Role of Cardiac CT in Infective Endocarditis: Current Evidence, Opportunities, and Challenges. Radiol. Cardiothorac. Imaging 2021, 3, e200378. [Google Scholar] [CrossRef] [PubMed]
- Roberts, W.C.; McIntosh, C.L.; Wallace, R.B. Aortic valve perforation with calcific aortic valve stenosis and without infective endocarditis or significant aortic regurgitation. Am. J. Cardiol. 1987, 59, 476–478. [Google Scholar] [CrossRef] [PubMed]
- Berridge, M.J.; Bootman, M.D.; Roderick, H.L. Calcium signalling: Dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 2003, 4, 517–529. [Google Scholar] [CrossRef] [Green Version]
- Clapham, D.E. Calcium signaling. Cell 2007, 131, 1047–1058. [Google Scholar] [CrossRef] [Green Version]
- Hanslik, T.; Flahault, A.; Vaillant, J.N.; Boulard, J.C.; Moulonguet-Doleris, L.; Prinseau, J.; Baglin, A. High risk of severe endocarditis in patients on chronic dialysis. Nephrol. Dial. Transplant. 1997, 12, 1301–1302. [Google Scholar] [CrossRef] [Green Version]
- Dibb, K.M.; Graham, H.K.; Venetucci, L.A.; Eisner, D.A.; Trafford, A.W. Analysis of cellular calcium fluxes in cardiac muscle to understand calcium homeostasis in the heart. Cell Calcium 2007, 42, 503–512. [Google Scholar] [CrossRef]
- Gorski, P.A.; Ceholski, D.K.; Hajjar, R.J. Altered myocardial calcium cycling and energetics in heart failure—A rational approach for disease treatment. Cell Metab. 2015, 21, 183–194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Luo, M.; Anderson, M.E. Mechanisms of altered Ca2+ handling in heart failure. Circ. Res. 2013, 113, 690–708. [Google Scholar] [CrossRef]
- Santulli, G.; Xie, W.; Reiken, S.R.; Marks, A.R. Mitochondrial calcium overload is a key determinant in heart failure. Proc. Natl. Acad. Sci. USA 2015, 112, 11389–11394. [Google Scholar] [CrossRef]
- Li, H.; Chen, J.; Hu, Y.; Cai, X.; Tang, D.; Zhang, P. Clinical value of serum calcium in elderly patients with sepsis. Am. J. Emerg. Med. 2022, 52, 208–211. [Google Scholar] [CrossRef]
- Celes, M.R.; Malvestio, L.M.; Suadicani, S.O.; Prado, C.M.; Figueiredo, M.J.; Campos, E.C.; Freitas, A.C.; Spray, D.C.; Tanowitz, H.B.; da Silva, J.S.; et al. Disruption of calcium homeostasis in cardiomyocytes underlies cardiac structural and functional changes in severe sepsis. PLoS ONE 2013, 8, e68809. [Google Scholar] [CrossRef] [PubMed]
- Guo, Y.; Li, P.; Guo, Q.; Shang, K.; Yan, D.; Du, S.; Lu, Y. Pathophysiology and Biomarkers in Acute Ischemic Stroke—A Review. Trop. J. Pharm. Res. 2013, 12, 1097–1105. [Google Scholar] [CrossRef] [Green Version]
- Campbell, B.C.V.; De Silva, D.A.; Macleod, M.R.; Coutts, S.B.; Schwamm, L.H.; Davis, S.M.; Donnan, G.A. Ischaemic stroke. Nat. Rev. Dis. Primers 2019, 5, 70. [Google Scholar] [CrossRef] [PubMed]
- Hannan, F.M.; Kallay, E.; Chang, W.; Brandi, M.L.; Thakker, R.V. The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases. Nat. Rev. Endocrinol. 2018, 15, 33–51. [Google Scholar] [CrossRef]
- Iamartino, L.; Brandi, M.L. The calcium-sensing receptor in inflammation: Recent updates. Front. Physiol. 2022, 13, 1059369. [Google Scholar] [CrossRef]
- Felderbauer, P.; Karakas, E.; Fendrich, V.; Bulut, K.; Werner, I.; Dekomien, G.; Klein, W.; Bartsch, D.; Schmidt, W.E. Pancreatitis in primary hyperparathyroidism-related hypercalcaemia is not associated with mutations in the CASR gene. Exp. Clin. Endocrinol. Diabetes 2007, 115, 527–529. [Google Scholar] [CrossRef]
- An, Z.; Ashraf, U.; Bacic Lima, D. A Case of Endocarditis Secondary to Bacteremia Caused by Obstructive Pyelonephritis from Infective Nephrolithiasis in the Setting of Untreated Hyperparathyroidism. Cureus 2022, 14, e21788. [Google Scholar] [CrossRef]
- Abdulfattah, O.; Rahman, E.U.; Shweta, F.; Datar, P.; Alnafoosi, Z.; Trauber, D.; Sam, M.; Enriquez, D.; Schmidt, F. Severe hypercalcemia in a patient with extrapulmonary Mycobacterium abscessus: Granuloma or immune reconstitution inflammatory syndrome? First case of Mycobacterium abscessus presenting as retroperitoneal lymphadenopathy with severe hypercalcemia: A case report and literature review. J. Community Hosp. Intern. Med. Perspect. 2018, 8, 331–338. [Google Scholar]
- Rodge, G.; Nagvekar, V.; Jhala, D.; George, A. Mycobacterium abscessus causing native valve endocarditis due to peripherally inserted central catheter line. J. Clin. Tuberc. Other Mycobact. Dis. 2017, 9, 19–20. [Google Scholar] [CrossRef]
- Bosch, X. Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease. JAMA 1998, 279, 532–534. [Google Scholar] [CrossRef] [Green Version]
- Adams, J.S. Vitamin D metabolite-mediated hypercalcemia. Endocrinol. Metab. Clin. N. Am. 1989, 18, 765–778. [Google Scholar] [CrossRef]
- Dandurand, K.; Ali, D.S.; Khan, A.A. Primary Hyperparathyroidism: A Narrative Review of Diagnosis and Medical Management. J. Clin. Med. 2021, 10, 1604. [Google Scholar] [CrossRef] [PubMed]
- Rozsai, B.; Horvath, M.; Savanya, M.; Kornyei, M.; Oprea, V.; Karteszi, J. Infective endocarditis with hypocalcaemia and facial dymorphism in an adolescent girl. Acta Paediatr. 2007, 96, 459–460. [Google Scholar] [CrossRef] [PubMed]
- Chopra, D.; Janson, P.; Sawin, C.T. Insensitivity to digoxin associated with hypocalcemia. N. Engl. J. Med. 1977, 296, 917–918. [Google Scholar] [CrossRef] [PubMed]
- Newman, D.B.; Fidahussein, S.S.; Kashiwagi, D.T.; Kennel, K.A.; Kashani, K.B.; Wang, Z.; Altayar, O.; Murad, M.H. Reversible cardiac dysfunction associated with hypocalcemia: A systematic review and meta-analysis of individual patient data. Heart Fail. Rev. 2014, 19, 199–205. [Google Scholar] [CrossRef]
- Baqi, D.H.; Ahmed, S.F.; Baba, H.O.; Fattah, F.H.; Salih, A.M.; Ali, R.M.; Saed, D.H.A.H.; Kakamad, F.H. Hypocalcemia as a cause of reversible heart failure: A case report and review of the literature. Ann. Med. Surg. 2022, 77, 103572. [Google Scholar] [CrossRef]
- Agus, H.Z.; Kahraman, S.; Arslan, C.; Yildirim, C.; Erturk, M.; Kalkan, A.K.; Yildiz, M. Systemic immune-inflammation index predicts mortality in infective endocarditis. J. Saudi Heart Assoc. 2020, 32, 58–64. [Google Scholar] [CrossRef]
- Zencirkiran Agus, H.; Kahraman, S.; Arslan, C.; Babur Guler, G.; Kalkan, A.K.; Panc, C.; Uzun, F.; Erturk, M.; Yildiz, M. Characterization, epidemiological profile and risk factors for clinical outcome of infective endocarditis from a tertiary care centre in Turkey. Infect. Dis. 2019, 51, 738–744. [Google Scholar] [CrossRef] [PubMed]
- McCusker, L.A.; Jenkins, N.P.; Hancock, J.E. Hypocalcaemia in a patient with congenital heart disease. J. R. Soc. Med. 2007, 100, 51–53. [Google Scholar] [CrossRef]
Criteria | Description |
---|---|
Major Criteria | Microbiologic (1) Positive blood culture for typical microorganisms b (2) Positive serology for Bartonella species (3) Positive molecular testing (PCR or sequencing) for typical microorganisms on blood or other sterile site Imaging (1) Evidence of endocardial involvement by echocardiography and/or cardiac computed tomography (CT) c (2) Evidence of endocardial involvement by PET/CT d Surgical Evidence of endocardial involvement by intraoperative inspection neither Major Imaging Criteria nor subsequent histologic or microbiologic confirmation |
Minor Criteria | Predisposition Predisposing heart condition or intravenous drug use Fever Temperature > 38.0 degree Centigrade (100.4 degrees Fahrenheit) Vascular phenomena Clinical or radiological evidence of arterial emboli, septic pulmonary infarcts, cerebral or splenic abscess, mycotic aneurysm, intracranial hemorrhage, conjunctival hemorrhages, Janeway lesions, purulent purpura Immunologic phenomena Immune-complex glomerulonephritis, Osler nodes, Roth spots, positive rheumatoid factor Microbiologic evidence Positive blood culture but not meeting major criterion as noted previously or serologic evidence of active infection with organism consistent with IE. Imaging Abnormal metabolic activity as detected by PET/CT within 3 months of implantation of prosthetic valve, ascending aortic graft (with concomitant evidence of valve), intracardiac device leads or other prosthetic material Physical examination New valvular regurgitation identified on auscultation if echocardiography is not available. |
Article Title | Authors | Discussion | Publication Year |
---|---|---|---|
Systemic immune-inflammation index predicts mortality in infective endocarditis | Agus et al. |
| 2020 [88] |
Characterization, epidemiological profile and risk factors for clinical outcome of infective endocarditis from a tertiary care centre in Turkey | Zencirkiran et al. |
| 2019 [89] |
Hypocalcaemia in a patient with congenital heart disease | McCusker LA, Jenkins NP, Hancock JE. |
| 2007 [90] |
Infective endocarditis with hypocalcaemia and facial dymorphism in an adolescent girl | Rózsai et al. |
| 2007 [84] |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kuo, Y.-S.; Tsai, Y.-M. Exploring the Risk Factors and Possible Role of Calcium in Infective Endocarditis. Diagnostics 2023, 13, 2386. https://doi.org/10.3390/diagnostics13142386
Kuo Y-S, Tsai Y-M. Exploring the Risk Factors and Possible Role of Calcium in Infective Endocarditis. Diagnostics. 2023; 13(14):2386. https://doi.org/10.3390/diagnostics13142386
Chicago/Turabian StyleKuo, Yen-Shou, and Yuan-Ming Tsai. 2023. "Exploring the Risk Factors and Possible Role of Calcium in Infective Endocarditis" Diagnostics 13, no. 14: 2386. https://doi.org/10.3390/diagnostics13142386